Biobank Clinical Genetics Maastricht (KG01) (KG01)

March 12, 2024 updated by: Maastricht University Medical Center

Biobank Clinical Genetics Maastricht

Collection of coded biomaterial and clinical data with patients consent for future research.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Collection of coded biomaterial and clinical data with patients consent for future research, with the purpose to indentify new gene mutation and prossibilities for treatment in the future.

Study Type

Observational

Enrollment (Estimated)

3600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Netherlands
    • Limburg
      • Maastricht, Limburg, Netherlands, 6229 HV
        • Recruiting
        • Maastricht University Medical Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

New patients visiting the out patient clinic of the department of Clinical Genetics of the Maastricht University Medical Hospital and who get blood or tissue sampled for DNA diagnostics.

Description

Inclusion Criteria:

  • New patients visiting the out patient clinic of the department of Clinical Genetics of the Maastricht University Medical Hospital
  • Withdrawal of body material for genetic diagnostics.

Exclusion Criteria:

  • Patient does not understand the Dutch language.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Genetic research in 5 areas.
Cardiogenetics; Intellectual Disability, Multiple Congenital Abnormalities and Rare Diseases; Oncogenetics; Dermatogenetics; Reproductive Genetics.
Genetic: Biobanking of biomaterial for future genetic research.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparing genes to discover unknown functions
Time Frame: Genes will be sequenced and compared, within an expected average of 6 months.
The biobanked bio material and medical data can be used for future research to learn more about the function of genes.
Genes will be sequenced and compared, within an expected average of 6 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Maastricht University Medical Center

Investigators

  • Study Director: W. van Zelst-Stams, MD, PhD, head of department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

March 1, 2024

Study Completion (Estimated)

January 1, 2035

Study Registration Dates

First Submitted

September 18, 2014

First Submitted That Met QC Criteria

October 13, 2014

First Posted (Estimated)

October 17, 2014

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • METC-14-4-077

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Genetic Disease

Clinical Trials on Biobanking of biomaterial for future genetic research.

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe